Authors:
Abraham, E
Laterre, PF
Garbino, J
Pingleton, S
Butler, T
Dugernier, T
Margolis, B
Kudsk, K
Zimmerli, W
Anderson, P
Reynaert, M
Lew, D
Lesslauer, W
Passe, S
Cooper, P
Burdeska, A
Modi, M
Leighton, A
Salgo, M
Van der Auwera, P
Citation: E. Abraham et al., Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients, CRIT CARE M, 29(3), 2001, pp. 503-510
Authors:
Moyle, G
Pozniak, A
Opravil, M
Clumeck, N
DelFraissy, JF
Johnson, M
Pelgrom, J
Reynes, J
Vittecoq, D
DeLora, P
Salgo, M
Duff, F
Citation: G. Moyle et al., The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues, J ACQ IMM D, 23(2), 2000, pp. 128-137
Authors:
Stellbrink, HJ
Hawkins, DA
Clumeck, N
Cooper, DA
Myers, R
Delfraissy, JF
Gill, MJ
Ramirez-Ronda, C
Vella, S
Salgo, M
Bragman, K
Citation: Hj. Stellbrink et al., Randomised, multicentre phase III study of saquinavir plus zidovudine pluszalcitabine in previously untreated or minimally pretreated HIV-infected patients, CLIN DRUG I, 20(5), 2000, pp. 295-307
Authors:
Babiker, A
Bartlett, J
Breckenridge, A
Collins, G
Coombs, R
Cooper, D
Creagh, T
Cross, A
Daniels, M
Darbyshire, J
Dawson, D
DeGruttola, V
DeMasi, R
Dolin, R
Eron, J
Fischl, M
Grossberg, S
Hamilton, J
Hammer, S
Hartigan, P
Henry, K
Hill, A
Hughes, M
Kahn, J
Katlama, C
Katzenstein, D
Kim, S
Mildvan, D
Montaner, J
Moore, M
Neaton, J
O'Brien, W
Ribaudo, H
Richman, D
Saag, M
Salgo, M
Saravolatz, L
Schooley, R
Seligmann, M
Staszewski, S
Struthers, L
Tierney, C
Tsiatis, A
Welles, S
Citation: A. Babiker et al., Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis, AIDS RES H, 16(12), 2000, pp. 1123-1133
Authors:
Abrams, D
Allan, D
Antunes, F
Breckenridge, A
Bruun, J
Cameron, W
Carbon, C
Chalmers, I
Chang, H
Chodakewitz, J
Clendenin, N
Clumeck, N
Collier, A
Collins, G
Cooper, E
Cooper, D
Danner, S
D'Aquila, R
DeGruttola, V
DeMasi, R
Dee, L
Deyton, L
Dixon, D
Farthing, C
Feinberg, J
Fischl, M
Flepp, M
Gartland, M
Gatell, J
Gazzard, B
Goebel, F
Gotzsche, P
Gringeri, A
Hall, D
Hamilton, J
Hammer, S
Hartigan, P
Heath-Chiozzi, M
Henry, K
Hill, A
Hirschel, B
Ioannidis, J
Kahn, J
Katlama, C
Katzenstein, D
Killen, J
King, E
de Loes, SK
Kravcik, S
Lange, J
Leavitt, R
Leonard, J
Maeland, A
Mannucci, P
Mathiesen, L
McDade, H
Meibohn, A
Melander, H
Merigan, T
Mulder, J
Myers, M
Neaton, J
Nessling, M
Perrin, L
Pettinelli, C
Phair, J
Phillips, A
Pinching, A
Poppa, A
Power, L
Reiss, P
Richman, D
Rooney, J
Rousseau, F
Rutherford, G
Salgo, M
Sandstrom, E
Saravolatz, L
Savidge, G
Schnittman, S
Schooley, R
Seligmann, M
Simberkoff, M
Skowron, G
Slade, P
Smith, D
Smith, RP
Soriano, V
Stanley, K
Stingl, G
Stoffels, P
Struthers, L
Tierney, C
Thompson, M
Van der Broeck, R
Van Leeuven, R
Van Weverling, G
Veenstra, J
Vella, S
Volberding, P
Weber, J
Winslow, D
Yeni, P
Yeo, J
Dormont, J
Sande, M
Weller, I
Babiker, A
Collins, R
Darbyshire, J
Duncan, W
Foulkes, M
Hughes, M
Peto, R
Peto, T
Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025